MATTHEWS INTERNATIONAL CORP current report, 28 September 2026

Matthews International Corporation — Form 8-K Summary

Business context and reporting period

The 8-K reports a board-composition change. The event occurred September 28, 2026; the related press release was issued October 1, 2026. This is not a financial-results filing and does not present a financial reporting period.

Board changes and business rationale

  • Directors Katherine E. Dietze and Morgan K. O’Brien notified the Board that they will not stand for re-election at the 2027 annual meeting of shareholders.
  • The Board determined to reduce its membership from ten to eight, effective immediately following that meeting.
  • The filing states that neither director’s decision resulted from a disagreement with the Company regarding its operations, policies, or practices.
  • The Board-size reduction is described as being in connection with the Company’s ongoing operational and portfolio simplification and cost-reduction initiatives.

Financial performance and outlook

The filing provides no revenue, profit, cash-flow, margin, debt, liquidity, or other current-period financial metrics, and gives no quantitative guidance. It identifies risks relevant to forward-looking statements, including the Company’s ability to achieve cost-reduction objectives and anticipated benefits of its joint venture transaction with Propelis, economic and foreign-exchange conditions, interest rates, material costs and tariffs, supply-chain disruptions, product demand and pricing, labor costs, cybersecurity, regulatory and environmental matters, and geopolitical events. The filing cautions that forward-looking statements are subject to risks and are not guarantees of future results.

Most important facts to verify

  • Whether the 2027 annual meeting takes place as expected and the Board reaches eight members afterward.
  • Whether the planned board reduction and broader simplification and cost-reduction initiatives produce measurable results in future filings.
  • Future disclosures on the Propelis joint venture and other risks cited in this 8-K.